Nordhealth AS Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	46.9	45.65	40.2	33.09	28.22	18.46
Other Revenue	4.93	5.19	5.48	3.74	2.83	1.84
Revenue	51.84	50.84	45.68	36.83	31.05	20.3
Revenue Growth (YoY)	7.97%	11.31%	24.03%	18.60%	52.96%	60.04%
Cost of Revenue	39.43	37.3	30.01	27.66	27.04	13.64
Gross Profit	12.4	13.54	15.67	9.16	4.01	6.67
Selling, General & Admin	2.15	2.15	2.38	2.59	2.76	1.12
Amortization of Goodwill & Intangibles	6.34	6.29	6.31	6.44	6.47	2.93
Other Operating Expenses	12.96	12.58	10.2	7.82	7.23	5.77
Operating Expenses	27.1	26.01	23.39	20.55	18.69	11.12
Operating Income	-14.7	-12.47	-7.73	-11.39	-14.68	-4.46
Interest Expense	-0.05	-0.04	-0.04	-0.01	-0.02	-0.04
Interest & Investment Income	0.07	0.07	0.22	0.15	0.11	-
Currency Exchange Gain (Loss)	-0.32	-0.32	0.12	-0.26	0.46	-0.15
Other Non Operating Income (Expenses)	0.25	0.47	0.78	0.7	0	-
EBT Excluding Unusual Items	-14.74	-12.29	-6.64	-10.81	-14.13	-4.65
Pretax Income	-14.74	-12.29	-6.64	-10.81	-14.13	-4.65
Income Tax Expense	0.46	0.39	1.04	0.33	0.14	0.09
Net Income	-15.21	-12.68	-7.67	-11.13	-14.26	-4.73
Net Income to Common	-15.21	-12.68	-7.67	-11.13	-14.26	-4.73
Shares Outstanding (Basic)	-	79	79	-	80	80
Shares Outstanding (Diluted)	-	79	79	-	80	80
Shares Change (YoY)	-	-0.32%	-	-	0.24%	-
EPS (Basic)	-	-0.16	-0.10	-	-0.18	-0.06
EPS (Diluted)	-	-0.16	-0.10	-	-0.18	-0.06
Free Cash Flow	-6.64	-4.37	-3.17	-10.95	-13.1	2.19
Free Cash Flow Per Share	-	-0.06	-0.04	-	-0.16	0.03
Gross Margin	23.93%	26.63%	34.30%	24.88%	12.93%	32.83%
Operating Margin	-28.36%	-24.52%	-16.91%	-30.92%	-47.27%	-21.96%
Profit Margin	-29.33%	-24.94%	-16.80%	-30.23%	-45.94%	-23.30%
Free Cash Flow Margin	-12.81%	-8.60%	-6.94%	-29.72%	-42.20%	10.79%
EBITDA	-7.78	-5.77	3.09	-1.25	-5.98	-0.22
EBITDA Margin	-15.00%	-11.34%	6.76%	-3.39%	-19.24%	-1.09%
D&A For EBITDA	6.92	6.7	10.81	10.14	8.7	4.24
EBIT	-14.7	-12.47	-7.73	-11.39	-14.68	-4.46
EBIT Margin	-28.36%	-24.52%	-16.91%	-30.92%	-47.27%	-21.96%
Revenue as Reported	52.08	51.08	45.81	36.83	31.05	20.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.